M. Sioud

Molecular basis for developing tumor-targeted siRNAs for future immunotherapy.

INTRODUCTION Certain immune signaling pathways contribute to cancer progression by promoting tumor immune evasion through immune checkpoint activation, immunosuppressive cytokine production, metabolic depletion, and altered intracellular signaling. Small interfering RNAs (siRNAs) provide a programmable strategy for sel...